WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.20, sa.2, ss.147-152, 2016 (ESCI)
Aim of the study: Sunitinib-related side effects may develop as a result of the pharmacokinetic pathway affects the of the drug.